Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes

The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes

研究成果: Article

1 引用 (Scopus)

抄録

Aim: To examine the contribution of PTPN2 coding variants to the risk of childhood-onset Type 1A diabetes. Methods: PTPN2 mutation analysis was carried out for 169 unrelated Japanese people with childhood-onset Type 1A diabetes. We searched for coding variants that were absent or extremely rare in the general population and were scored as damaging by multiple in silico programs. We performed mRNA analysis and three-dimensional structural prediction of the detected variants, when possible. We also examined possible physical links between these variants and previously reported risk SNPs as well as clinical information from variant-positive children. Results: One frameshift variant (p.Q286Yfs*24) and two probably damaging missense substitutions (p.C232W and p.R350Q) were identified in one child each. Of these, p.Q286Yfs*24 and p.C232W were hitherto unreported, while p.R350Q accounted for 2/121,122 alleles of the exome datasets. The p.Q286Yfs*24 variant did not encode stable mRNA, and p.C232W appeared to affect the structure of the tyrosine-protein phosphatase domain. The three variants were physically unrelated to known risk SNPs. The variant-positive children manifested Type 1A diabetes without additional clinical features and invariably carried risk human leukocyte antigen alleles. Conclusions: The results provide the first indication that PTPN2 variants contribute to the risk of Type 1A diabetes, independently of known risk SNPs. PTPN2 coding variants possibly induce non-specific Type 1A diabetes phenotypes in individuals with human leukocyte antigen-mediated disease susceptibility. Our findings warrant further validation.

元の言語English
ページ（範囲）376-380
ページ数5
ジャーナルDiabetic Medicine
巻35
発行部数3
DOI
出版物ステータスPublished - 03-2018

Fingerprint

Single Nucleotide Polymorphism
Proteins
HLA Antigens
Alleles
Exome
Messenger RNA
Disease Susceptibility
Computer Simulation
Tyrosine
Phenotype
Mutation
Population
Datasets
Protein Domains

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

これを引用

The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes (2018). Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes. Diabetic Medicine, 35(3), 376-380. https://doi.org/10.1111/dme.13566
The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes. / Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes. ：: Diabetic Medicine. 2018 ; 巻 35, 番号 3. pp. 376-380.
@article{41fce3add18244e699e4c272b6dbd474,
title = "Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes",
abstract = "Aim: To examine the contribution of PTPN2 coding variants to the risk of childhood-onset Type 1A diabetes. Methods: PTPN2 mutation analysis was carried out for 169 unrelated Japanese people with childhood-onset Type 1A diabetes. We searched for coding variants that were absent or extremely rare in the general population and were scored as damaging by multiple in silico programs. We performed mRNA analysis and three-dimensional structural prediction of the detected variants, when possible. We also examined possible physical links between these variants and previously reported risk SNPs as well as clinical information from variant-positive children. Results: One frameshift variant (p.Q286Yfs*24) and two probably damaging missense substitutions (p.C232W and p.R350Q) were identified in one child each. Of these, p.Q286Yfs*24 and p.C232W were hitherto unreported, while p.R350Q accounted for 2/121,122 alleles of the exome datasets. The p.Q286Yfs*24 variant did not encode stable mRNA, and p.C232W appeared to affect the structure of the tyrosine-protein phosphatase domain. The three variants were physically unrelated to known risk SNPs. The variant-positive children manifested Type 1A diabetes without additional clinical features and invariably carried risk human leukocyte antigen alleles. Conclusions: The results provide the first indication that PTPN2 variants contribute to the risk of Type 1A diabetes, independently of known risk SNPs. PTPN2 coding variants possibly induce non-specific Type 1A diabetes phenotypes in individuals with human leukocyte antigen-mediated disease susceptibility. Our findings warrant further validation.",
author = "{The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes} and M. Okuno and T. Ayabe and I. Yokota and I. Musha and K. Shiga and T. Kikuchi and N. Kikuchi and A. Ohtake and A. Nakamura and K. Nakabayashi and K. Okamura and Y. Momozawa and M. Kubo and J. Suzuki and T. Urakami and T. Kawamura and S. Amemiya and T. Ogata and S. Sugihara and M. Fukami",
year = "2018",
month = "3",
doi = "10.1111/dme.13566",
language = "English",
volume = "35",
pages = "376--380",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "3",

}

The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes 2018, 'Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes', Diabetic Medicine, 巻. 35, 番号 3, pp. 376-380. https://doi.org/10.1111/dme.13566

Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes. / The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes.

：: Diabetic Medicine, 巻 35, 番号 3, 03.2018, p. 376-380.

研究成果: Article

TY - JOUR

T1 - Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes

AU - The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes

AU - Okuno, M.

AU - Ayabe, T.

AU - Yokota, I.

AU - Musha, I.

AU - Shiga, K.

AU - Kikuchi, T.

AU - Kikuchi, N.

AU - Ohtake, A.

AU - Nakamura, A.

AU - Nakabayashi, K.

AU - Okamura, K.

AU - Momozawa, Y.

AU - Kubo, M.

AU - Suzuki, J.

AU - Urakami, T.

AU - Kawamura, T.

AU - Amemiya, S.

AU - Ogata, T.

AU - Sugihara, S.

AU - Fukami, M.

PY - 2018/3

Y1 - 2018/3

N2 - Aim: To examine the contribution of PTPN2 coding variants to the risk of childhood-onset Type 1A diabetes. Methods: PTPN2 mutation analysis was carried out for 169 unrelated Japanese people with childhood-onset Type 1A diabetes. We searched for coding variants that were absent or extremely rare in the general population and were scored as damaging by multiple in silico programs. We performed mRNA analysis and three-dimensional structural prediction of the detected variants, when possible. We also examined possible physical links between these variants and previously reported risk SNPs as well as clinical information from variant-positive children. Results: One frameshift variant (p.Q286Yfs*24) and two probably damaging missense substitutions (p.C232W and p.R350Q) were identified in one child each. Of these, p.Q286Yfs*24 and p.C232W were hitherto unreported, while p.R350Q accounted for 2/121,122 alleles of the exome datasets. The p.Q286Yfs*24 variant did not encode stable mRNA, and p.C232W appeared to affect the structure of the tyrosine-protein phosphatase domain. The three variants were physically unrelated to known risk SNPs. The variant-positive children manifested Type 1A diabetes without additional clinical features and invariably carried risk human leukocyte antigen alleles. Conclusions: The results provide the first indication that PTPN2 variants contribute to the risk of Type 1A diabetes, independently of known risk SNPs. PTPN2 coding variants possibly induce non-specific Type 1A diabetes phenotypes in individuals with human leukocyte antigen-mediated disease susceptibility. Our findings warrant further validation.

AB - Aim: To examine the contribution of PTPN2 coding variants to the risk of childhood-onset Type 1A diabetes. Methods: PTPN2 mutation analysis was carried out for 169 unrelated Japanese people with childhood-onset Type 1A diabetes. We searched for coding variants that were absent or extremely rare in the general population and were scored as damaging by multiple in silico programs. We performed mRNA analysis and three-dimensional structural prediction of the detected variants, when possible. We also examined possible physical links between these variants and previously reported risk SNPs as well as clinical information from variant-positive children. Results: One frameshift variant (p.Q286Yfs*24) and two probably damaging missense substitutions (p.C232W and p.R350Q) were identified in one child each. Of these, p.Q286Yfs*24 and p.C232W were hitherto unreported, while p.R350Q accounted for 2/121,122 alleles of the exome datasets. The p.Q286Yfs*24 variant did not encode stable mRNA, and p.C232W appeared to affect the structure of the tyrosine-protein phosphatase domain. The three variants were physically unrelated to known risk SNPs. The variant-positive children manifested Type 1A diabetes without additional clinical features and invariably carried risk human leukocyte antigen alleles. Conclusions: The results provide the first indication that PTPN2 variants contribute to the risk of Type 1A diabetes, independently of known risk SNPs. PTPN2 coding variants possibly induce non-specific Type 1A diabetes phenotypes in individuals with human leukocyte antigen-mediated disease susceptibility. Our findings warrant further validation.

UR - http://www.scopus.com/inward/record.url?scp=85041954710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041954710&partnerID=8YFLogxK

U2 - 10.1111/dme.13566

DO - 10.1111/dme.13566

M3 - Article

C2 - 29247561

AN - SCOPUS:85041954710

VL - 35

SP - 376

EP - 380

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 3

ER -

The Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes. Protein-altering variants of PTPN2 in childhood-onset Type 1A diabetes. Diabetic Medicine. 2018 3;35(3):376-380. https://doi.org/10.1111/dme.13566

文献にアクセス